Clinical Trial

The Clinical Research of Traditional Chinese Medicine Compound Formulas

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated September 4, 2025 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
To observe the efficacy and safety of Shenkangling, a traditional Chinese medicine decoction, for renal ischemia-reperfusion injury, and to provide evidence-based medical evidence and ideas for clinical therapeutic use.
Trial Details
NCT Number NCT07153731
Lead Sponsor The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Conditions Urologic Injuries, Urology
Enrollment 100 participants
Start Date 2025-10-01
Primary Completion 2025-10-01 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-04